Expert Interviews

As researchers continue to measure the impacts of the COVID-19 pandemic on public health, Hashim Zaibak, PharmD, discusses the evolution of community pharmacies in a postpandemic world.

From Scripts to Screens: AAP’s Ginny Langbehn Shares Winning Digital Strategies for Independent Pharmacies

When independent and retail storefronts close across the country, creating a lack of pharmacy services in the community, pharmacy deserts arise.

Michael Murphy, PharmD, MBA, discusses the increasingly prominent impacts of pharmacy deserts, highlighting discrepancies in the term's definition and the financial pressures impacting sustainability.

With expertise into the growing issue of pharmacy deserts, Michael Murphy, PharmD, MBA, discussed exactly what patients are losing when their community no longer has pharmacy access.

Michael Murphy, PharmD, MBA, joined Drug Topics to present his ideas for correcting the growing issue of pharmacy deserts and unprecedented closures across the country.

Kristen Jones, PharmD, discusses leadership strategies in pharmacy management that prioritize emotional intelligence and communication for enhanced team performance and patient care.

Pharmacy professionals evolve into strategic leaders, mastering emotional intelligence and management skills to navigate complex workplace dynamics and enhance patient care.

Kristen Jones, PharmD, discusses challenging traditional workplace paradigms by emphasizing the human element in pharmaceutical operations.

With the company’s dedication to providing crucial data for pharmacy stakeholders, IQVIA’s Lead Research Director Michael Kleinrock discussed the current trends in patients’ medication use.

Michael Murphy, PharmD, MBA, provided insights on his research regarding pharmacy deserts, who they impact the most, and the methods needed to improve them in the US.

In part 4 of our interview with Michael Kleinrock, lead director of research at IQVIA, he discussed how trends in medication use are currently impacting pharmacy businesses.

Michael Murphy, PharmD, MBA, discusses how the lack of a universal definition for pharmacy deserts is leading to a significant impact on patients’ access and outcomes.

Brooklyn Morgan, PharmD, discusses the transformation of pharmacy practice from a regulatory model to a more flexible approach.

Thomas Sherrer, PharmD, emphasizes teamwork and technology in inventory management to enhance patient safety and reduce medication errors.

Thomas Sherrer, PharmD, advocates for a team-driven, tech-enhanced approach to pharmacy inventory management, boosting patient care and operational efficiency.

Michael Kleinrock, lead director of research at IQVIA Institute for Human Data Science, discusses the current trends in medication use and where these drivers may be headed in the near future.

Brooklyn Morgan, PharmD, director of state policy at the National Alliance of State Pharmacy Associations, emphasizes the importance of making the pharmacist's voice heard.

Congressman Buddy Carter (R-GA) champions the PBM Reform Act of 2025, aiming to enhance drug price transparency and empower pharmacists in healthcare delivery.

Thomas Sherrer, PharmD, co-owner of Poole's Pharmacy, describes implementing multiple tracking methods to stay ahead of drug shortages.

Michael Kleinrock from IQVIA joined Drug Topics to discuss his company’s recently released report, Understanding the Use of Medicines in the US 2025.

Crystal Lennartz, president of Health Mart & Health Mart Atlas at McKesson, discusses challenges that independent pharmacies are facing in today's health care landscape.

Jeanine Singer, senior vice president of national and key accounts at McKesson, discusses the company's approach to empowering pharmacists and strengthening the community pharmacy ecosystem.

Through platforms like Health Mart Atlas, the company is providing pharmacies with tools to better understand their financial landscape.

Thomas Sherrer, PharmD, emphasizes the importance of a team-based approach to inventory control.

Buddy Carter, PBM, US Representative (R-GA), emphasizes the critical role of pharmacists, particularly during the COVID-19 pandemic, and advocates for provider status recognition.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joins Drug Topics to discuss her extensive background in managing patients’ insulin regimens.

With federal reform continuing to stall, Drug Topics caught up with Iowa State Representative Brett Barker, PharmD, to discuss how his state is regulating pharmacy benefit managers.